Soleno Therapeutics Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC SLNO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

72,360

Value ($000)

3,350

Weight

0.0%

2024 Q1 - 2025 Q4 (8 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,350	0.0%	72,360	12/31/2025
2025 Q3	11/14/2025	3,947	0.0%	58,392	9/30/2025
2025 Q2	8/14/2025	7,457	0.0%	89,005	6/30/2025
2025 Q1	5/19/2025	2,909	0.0%	40,715	3/31/2025
2024 Q4	2/14/2025	1,236	0.0%	27,504	12/31/2024
2024 Q3	11/14/2024	1,113	0.0%	22,042	9/30/2024
2024 Q2	8/14/2024	960	0.0%	23,531	6/30/2024
2024 Q1	5/15/2024	378	0.0%	8,824	3/31/2024